Robert Clarke

Robert Clarke is a biotech entrepreneur with over 20 years of experience in drug development and delivery, ranging from start-ups to advanced clinical phases. Currently, they serve as the Chief Executive Officer and Co-Founder of Kinaset Therapeutics, where they leverage their extensive background in fundraising and corporate development to advance product innovation. Clarke has previous experience as an Associate Director at Alkermes, a Vice President at Pulmatrix, and a Research Fellow at Harvard University. They hold a Bachelor of Science in Biomedical Engineering from Boston University and are pursuing a PhD at The Johns Hopkins University. Clarke is also actively involved with advisory boards at Boston University and The Johns Hopkins University and serves as a board member at Spexis AG.